iShares Neuroscience and Healthcare ETF
IBRN
5 hedge funds and large institutions have $2.93M invested in iShares Neuroscience and Healthcare ETF in 2024 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 1 closing their positions.
100% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 1
25% more funds holding
Funds holding: 4 → 5 (+1)
10% more capital invested
Capital invested by funds: $2.67M → $2.93M (+$257K)
2.5% more ownership
Funds ownership: 75.46% → 77.96% (+2.5%)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
+$254K |
| 2 |
PS
Principal Securities
Des Moines,
Iowa
|
+$18.3K |
| 3 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$14.2K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FTUS
Flow Traders U.S.
New York
|
-$191K |
| 2 |
TFF
The Family Firm
Bethesda,
Maryland
|
-$2.15K |
IBRN Hedge Fund Activity: Q3 2024 in Review
5 of the 6,978 institutional investors tracked by Wall St. Rank reported a position in iShares Neuroscience and Healthcare ETF (IBRN) for Q3 2024, worth a combined $2.93M — up 9.6% from $2.67M a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new IBRN positions and 1 closed out — a net gain of 1 holder — while 1 added to existing stakes and 1 trimmed.
The largest buyer was Jane Street, opening a new position worth an estimated $254K. The largest seller was Flow Traders U.S., cutting an estimated $191K.
- 5 institutional investors held iShares Neuroscience and Healthcare ETF (IBRN) as of Q3 2024, up from 4 in Q2 2024.
- Funds reported $2.93M of iShares Neuroscience and Healthcare ETF stock for Q3 2024, up 9.6% quarter-over-quarter.
- 2 funds opened new iShares Neuroscience and Healthcare ETF positions in Q3 2024 and 1 closed out, a net change of +1 holder.
- The largest iShares Neuroscience and Healthcare ETF buyer in Q3 2024 was Jane Street, an estimated $254K added.
- The largest iShares Neuroscience and Healthcare ETF seller in Q3 2024 was Flow Traders U.S., an estimated $191K sold.
Based on aggregated 13F filings for Q3 2024.